Skip to main contentSkip to navigation
Sirius Investors
IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.

IDXX
NASDAQHealthcare

IDEXX Laboratories, Inc. (IDXX) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate IDEXX Laboratories, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
51.37
Weak
WeakModerateStrong
P/B Ratio
33.75
Weak
WeakModerateStrong
Earnings Yield
1.96%
Yield Trap
WeakModerateStrong

Profitability Health

2025
Return on Equity
65.99%
Strong
WeakModerateStrong
Operating Margin
31.60%
Strong
WeakModerateStrong
Net Profit Margin
24.62%
Strong
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
10.42%
Strong
WeakModerateStrong
Net Income Growth
19.33%
Strong
WeakModerateStrong
EPS Growth
22.28%
Strong
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.17
Moderate
WeakModerateStrong
Quick Ratio
0.84
Weak
WeakModerateStrong
Asset Turnover
1.28x
Strong
WeakModerateStrong
Inventory Turnover
4.35x
Moderate
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
1.94%
Weak
WeakModerateStrong
EV / Free Cash Flow
52.29x
Weak
WeakModerateStrong
Net Debt / EBITDA
0.61x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.974
Strong
WeakModerateStrong
Return on Invested Capital
40.27%
Strong
WeakModerateStrong
Cash Conversion Cycle
118.14 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for IDXX.

View Financial Statements